Is systemic infliximab therapy effective for retinal cavernous hemangioma?

Saudi Med J. 2014 Sep;35(9):1127-30.

Abstract

A 10-month-old infant with the diagnosis of retinal cavernous hemangioma involving the macula presented with an outward deviation of the right eye that has been noticed by her parents. Examination revealed a clearing vitreous hemorrhage, and grape-like clusters filled with blood in the posterior pole. After 4 cycles of intravenous infliximab over the period of 3 months, no evident change was noted on the size of the cavernous hemangioma.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Hemangioma, Cavernous / drug therapy*
  • Humans
  • Infant
  • Infliximab
  • Retinal Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Infliximab